Developing sevuparin
to help patients with severe conditions and high unmet medical need
Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with sepsis/septic shock, a severe and often fatal condition.
LATEST NEWS
SEVUPARIN AND SEPSIS IN LESS THAN THREE MINUTES